Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02940743 · ClinicalTrials.gov registry record · NA
Behavioral Management of Phosphorus in Hemodialysis Patients
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02940743 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT02940743, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this randomized clinical trial is to evaluate alternative technology-supported behavioral approaches to engaging 42 maintenance hemodialysis (HD) patients with persistent hyperphosphatemia in phosphorus binder adherence and dietary phosphorus restriction. Participants will be randomized to 1 of 3 intervention groups: (1) Education (Edu); (2) Edu + Self-Monitoring (SM); or (3) Edu + SM + Social Cognitive Theory (SCT)-based training program.
Interventions
- BEHAVIORAL Education (Edu)
- BEHAVIORAL SM intervention
- BEHAVIORAL Social Cognitive Therapy (SCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-04-23 |
| Est. Completion | 2018-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02940743
The ClinicalTrials.gov registry entry for NCT02940743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Education (Edu) is the first listed.
NCT02940743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02940743 about?
NCT02940743 is a clinical study titled "Behavioral Management of Phosphorus in Hemodialysis Patients". The purpose of this randomized clinical trial is to evaluate alternative technology-supported behavioral approaches to engaging 42 maintenance hemodialysis (HD) patients with persistent hyperphosphatemia in phosphorus binder adherence and dietary phosphorus restriction. Participants will be randomiz...
What is the current status of trial NCT02940743?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-04-23. Estimated completion is 2018-05-01.
What interventions are being tested in trial NCT02940743?
The interventions under investigation include: Education (Edu) (BEHAVIORAL), SM intervention (BEHAVIORAL), Social Cognitive Therapy (SCT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02940743?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.